Company Filing History:
Years Active: 2018
Title: Jens Ole Eriksen: Innovator in Cancer Treatment
Introduction
Jens Ole Eriksen is a notable inventor based in Værløse, Denmark. He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His dedication to improving therapeutic methods has positioned him as a key figure in medical advancements.
Latest Patents
Jens Ole Eriksen holds a patent titled "Therapeutic applications of calcium electroporation to effectively induce tumor necrosis." This patent demonstrates the effectiveness of electroporation with calcium ions on cutaneous and subcutaneous nodules. The invention reveals that a solution containing calcium ions at a concentration of at least 0.1 M is highly beneficial in treating neoplasms, such as cancer. The method involves transiently permeabilizing the cell membranes of the neoplasm before, during, and/or after administering the calcium solution, with a specific volume ratio of 0.2 to 0.8.
Career Highlights
Jens Ole Eriksen is affiliated with Herlev Hospital, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to revolutionize cancer treatment methodologies.
Collaborations
He collaborates with esteemed colleagues, including Karen Julie Gehl and Stine Krog Frandsen, who contribute to his research efforts and enhance the impact of his innovations.
Conclusion
Jens Ole Eriksen's contributions to cancer treatment through his patent on calcium electroporation exemplify the importance of innovation in medicine. His work continues to inspire advancements in therapeutic applications for neoplasms.